Tombot

Santa Clarita, California, United States

Tombot will make the first FDA-regulated medical grade realistic robotic animal that transforms the daily life of individuals, families and communities facing health adversities. Originally designed to meet the specific medical needs of seniors with dementia, Tombot Puppies have also been preordered for other medical conditions, long inpatient stays, and arduous outpatient treatments at hospitals. Peer-reviewed studies show that robotic animals positively affect some users’ ability to cope with stress, anxiety, loneliness, depression, and pain, reducing their need for psychotropic and opioid medications. Using groundbreaking technology, fabrics, and animatronic techniques, Jim Henson’s Creature Shop brought the Tombot to life with uniquely life-like expressions, behaviors, and quality.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Tombot on @MedStartr Today #Anxiety #Depression #Pain #StressBurnout #SubstanceAbuse #MedMo #MedStartrVentures

https://www.medstartr.ai/s/jL5QhprjJGk

Get Involved in Tombot

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: tombot.com/

Disease Areas

Anxiety Depression Pain Stress & Burnout

Technologies

RoboticsMedical DevicesTherapeutic Devices

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Tombot?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.